New instrument automates tissue processing for researchers in cancer, immunology and other science fields VANCOUVER, BC – To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator… Read More
First and only BTK inhibitor approved for 1L MCL based on ECHO results, which showed Calquence plus chemoimmunotherapy extended progression-free survival by over 16 months vs. chemoimmunotherapy alone MISSISSAUGA, ON… Read More
A long-time Terry Fox supporter and prominent surgeon, leader and advocate for Indigenous health and research, Dr. Nadine Caron has been inducted into the Canadian Medical Hall of Fame. The… Read More
Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/Gro Significantly reduces levels of inflammasome marker, NLRP3, a key contributor to neurodegeneration Reduces key pro-inflammatory markers, independent… Read More
Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indications VANCOUVER, BC & BOSTON,… Read More
